Sato Y - Search Results

1

Structure and expression of the mouse cardiac calsequestrin gene.

Frank KF, Mesnard-Rouiller L, Chu G, Young KB, Zhao W, Haghighi K, Sato Y, Kranias EG. Frank KF, et al. Among authors: sato y. Basic Res Cardiol. 2001 Nov;96(6):636-44. doi: 10.1007/s003950170016. Basic Res Cardiol. 2001. PMID: 11770083

2

Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice.

Sato Y, Ferguson DG, Sako H, Dorn GW 2nd, Kadambi VJ, Yatani A, Hoit BD, Walsh RA, Kranias EG. Sato Y, et al. J Biol Chem. 1998 Oct 23;273(43):28470-7. doi: 10.1074/jbc.273.43.28470. J Biol Chem. 1998. PMID: 9774476 Free article.

3

Cardiac-specific overexpression of calsequestrin results in left ventricular hypertrophy, depressed force-frequency relation and pulsus alternans in vivo.

Schmidt AG, Kadambi VJ, Ball N, Sato Y, Walsh RA, Kranias EG, Hoit BD. Schmidt AG, et al. Among authors: sato y. J Mol Cell Cardiol. 2000 Sep;32(9):1735-44. doi: 10.1006/jmcc.2000.1209. J Mol Cell Cardiol. 2000. PMID: 10966834

4

Rescue of contractile parameters and myocyte hypertrophy in calsequestrin overexpressing myocardium by phospholamban ablation.

Sato Y, Kiriazis H, Yatani A, Schmidt AG, Hahn H, Ferguson DG, Sako H, Mitarai S, Honda R, Mesnard-Rouiller L, Frank KF, Beyermann B, Wu G, Fujimori K, Dorn GW 2nd, Kranias EG. Sato Y, et al. J Biol Chem. 2001 Mar 23;276(12):9392-9. doi: 10.1074/jbc.M006889200. Epub 2000 Dec 13. J Biol Chem. 2001. PMID: 11115498 Free article.

5

Hypertrophy and functional alterations in hyperdynamic phospholamban-knockout mouse hearts under chronic aortic stenosis.

Kiriazis H, Sato Y, Kadambi VJ, Schmidt AG, Gerst MJ, Hoit BD, Kranias EG. Kiriazis H, et al. Among authors: sato y. Cardiovasc Res. 2002 Feb 1;53(2):372-81. doi: 10.1016/s0008-6363(01)00487-4. Cardiovasc Res. 2002. PMID: 11827688

6

A human phospholamban promoter polymorphism in dilated cardiomyopathy alters transcriptional regulation by glucocorticoids.

Haghighi K, Chen G, Sato Y, Fan GC, He S, Kolokathis F, Pater L, Paraskevaidis I, Jones WK, Dorn GW 2nd, Kremastinos DT, Kranias EG. Haghighi K, et al. Among authors: sato y. Hum Mutat. 2008 May;29(5):640-7. doi: 10.1002/humu.20692. Hum Mutat. 2008. PMID: 18241046 Free PMC article.

7

Phospholamban deficiency alters inactivation kinetics of L-type Ca2+ channels in mouse ventricular myocytes.

Masaki H, Sato Y, Luo W, Kranias EG, Yatani A. Masaki H, et al. Among authors: sato y. Am J Physiol. 1997 Feb;272(2 Pt 2):H606-12. doi: 10.1152/ajpheart.1997.272.2.H606. Am J Physiol. 1997. PMID: 9124415

8

beta-Adrenergic regulation of cAMP and protein phosphorylation in phospholamban-knockout mouse hearts.

Kiss E, Edes I, Sato Y, Luo W, Liggett SB, Kranias EG. Kiss E, et al. Among authors: sato y. Am J Physiol. 1997 Feb;272(2 Pt 2):H785-90. doi: 10.1152/ajpheart.1997.272.2.H785. Am J Physiol. 1997. PMID: 9124439

9

Transgenic approaches to define the functional role of dual site phospholamban phosphorylation.

Luo W, Chu G, Sato Y, Zhou Z, Kadambi VJ, Kranias EG. Luo W, et al. Among authors: sato y. J Biol Chem. 1998 Feb 20;273(8):4734-9. doi: 10.1074/jbc.273.8.4734. J Biol Chem. 1998. PMID: 9468536 Free article.

10

Overexpression of phospholamban alters inactivation kinetics of L-type Ca2+ channel currents in mouse atrial myocytes.

Masaki H, Sako H, Kadambi VJ, Sato Y, Kranias EG, Yatani A. Masaki H, et al. Among authors: sato y. J Mol Cell Cardiol. 1998 Feb;30(2):317-25. doi: 10.1006/jmcc.1997.0594. J Mol Cell Cardiol. 1998. PMID: 9515008

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,300 results

Search Page

Filters